About The Position

The Senior Director, External Innovation owns external innovation strategy and execution for one or more designated therapeutic or disease areas within Neuroscience, such as neurodegeneration, pain, psychiatry/psychedelics, or sleep-wake. The role leads partnering projects independently from opportunity identification through scientific due diligence, recommendation, and deal completion. It translates strategic theses into deal constructs and serves as the scientific point of contact for partners, combining deep scientific and technical judgment with business and deal-structuring expertise. The role may mentor or directly supervise more junior External Innovation colleagues. External Innovation supports Lilly’s portfolio strategy through identification, rigorous evaluation, and advancement of external opportunities. Neuroscience opportunities may include research collaborations, platform and asset licenses, equity investments, and acquisitions involving private or public companies and modalities such as small molecules, antibodies, oligonucleotides, gene therapies, and blood–brain barrier delivery technologies. The position develops external strategy and search priorities in collaboration with senior management; identifies and evaluates opportunities; leads scientific due diligence and partner interactions; develops initial deal constructs; aligns internal stakeholders; and works with cross-functional colleagues to advance, negotiate, and transition deals. It represents external innovation for the assigned area in internal governance and external forums, maintains knowledge of scientific and competitive developments, and supports junior colleagues on deals.

Requirements

  • Bachelor’s degree or higher in a relevant area of science and/or healthcare.
  • At least 10 years of experience in the pharmaceutical industry, biotech, or ventures.
  • At least 3 years of experience in external innovation, search and evaluation, business development, or venture roles related to the assigned area(s).

Nice To Haves

  • Ph.D. or equivalent in a relevant area of science.
  • MBA degree.
  • Strong scientific background in the area of interest, with a track record of accomplishments in drug discovery or development.
  • Deep understanding of neuroscience disease biology, unmet need, target landscape, emerging modalities and technologies, biomarkers, competition, and portfolio trends across neurodegeneration, pain, psychiatry, and sleep-wake disorders.
  • Strong business acumen and understanding of R&D, commercialization, portfolio strategy, and finance.
  • Strong understanding of the strategic and financial considerations underlying deal priorities and partner considerations, and working knowledge of a wide variety of deal structures and term-sheet economics.
  • Ability to work effectively and drive success within highly integrated cross-functional teams spanning science, business, finance, legal, Catalyze 360, and Corporate Business Development.
  • Ability to set strategy and progress a portfolio of deals with minimal guidance.
  • Strong ability to influence and manage senior leadership and key internal and external stakeholders while collaborating effectively.
  • Excellent written and verbal communication, including concise decision-ready assessments and presenting and defending recommendations to senior leadership.
  • Intellectual honesty, decision-making agility, comfort with ambiguity, and ability to prioritize multiple concurrent evaluations.
  • Familiarity with AI-enabled landscape, competitive-intelligence, and scouting tools.
  • Experience in new company creation, venture capital interactions, or spinout management.
  • Track record of successful partnership execution; deal sheet preferred.

Responsibilities

  • Own external innovation strategy and approach for assigned Neuroscience therapeutic or disease areas, developing search themes, landscapes, and go/no-go criteria with senior management.
  • Identify external innovation and collaboration opportunities through landscape screens, conferences, and networks across biotech, academia, venture capital, and pharma.
  • Lead early opportunity assessment and triage, and serve as a key contact for partners.
  • Lead initial technical evaluations and own in-depth scientific due diligence for the designated disease area, identifying critical questions, opportunities, and risks and aligning stakeholders.
  • Independently lead partnering projects, including partner interactions, due diligence, written recommendations, management presentations, and collaboration with Corporate Business Development on deal structure and progression to close.
  • Provide timely, constructive scientific feedback to potential partners and nurture long-term relationships.
  • Translate scientific and strategic theses into initial deal constructs, including structure, scope, value rationale, and business terms aligned with scientific and clinical milestones; lead early commercial conversations with partners.
  • Build internal conviction and stakeholder alignment behind priority opportunities across therapeutic area, Business Unit, and Corporate Business Development leadership.
  • Partner with Due Diligence, Corporate Business Development, Alliance & Innovation Management, Legal and Intellectual Property, Lilly Research Laboratories, and therapeutic-area functions to vet, negotiate, and integrate opportunities; remain the scientific contact through handover.
  • Represent external innovation for assigned areas in lead-team meetings and deal-flow reviews, and select topics and presentations for senior management forums.
  • Maintain deep knowledge of internal portfolio projects, external opportunities, and the competitive landscape across discovery, clinical development, and platforms; monitor external assets and competitor data readouts.
  • Represent Lilly’s strategic and external innovation priorities at external meetings, roundtables, and invited presentations, and maintain external networks.
  • Mentor and support junior External Innovation colleagues by reviewing management decks, advising on deal structure, and guiding partner interactions.

Benefits

  • Company bonus eligibility for full-time equivalent employees, depending in part on company and individual performance.
  • Eligibility to participate in a company-sponsored 401(k).
  • Pension.
  • Vacation benefits.
  • Eligibility for medical, dental, vision, and prescription drug benefits.
  • Flexible benefits, such as healthcare and/or dependent day care flexible spending accounts.
  • Life insurance and death benefits.
  • Certain time-off and leave-of-absence benefits.
  • Well-being benefits, including an employee assistance program, fitness benefits, and employee clubs and activities.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service